Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00998660 · ClinicalTrials.gov registry record · Phase 4

RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)

A Phase 4 study, sponsored by MedtronicNeuro.

Completed
Registry status
Phase 4
Development phase
100
Enrollment target

NCT00998660: Completed Phase 4 study, sponsored by MedtronicNeuro.

NCT00998660 is a Phase 4 study that has completed, run by MedtronicNeuro. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00998660, a Phase 4 study, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
Phase 4
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this study is to assess the recharge feature of the Activa RC System in patients who are receiving Deep Brain Stimulation (DBS) for Parkinson's Disease (PD), Essential Tremor (ET), or dystonia.

Primary Outcome

Subject-months of follow-up were defined as the time from device activation to the earlier of a subject's 3-month visit or until the subject exited from the study. Any user-related battery depletion adverse events requiring intervention by a health care professional (HCP) and/or the HCP's designee were collected. The event rate per 100 subject-months of follow-up is defined as the number of user-related battery depletion events divided by the total subject follow-up months through the 3-month vi

Interventions

  • DEVICE Activa RC

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2009-07
Est. Completion 2013-07
Phase Phase 4
MedtronicNeuro

51 total trials

What the finished NCT00998660 record still lists

NCT00998660 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Activa RC is the first listed.

NCT00998660 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00998660 about?

NCT00998660 is a clinical study titled "RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)". The purpose of this study is to assess the recharge feature of the Activa RC System in patients who are receiving Deep Brain Stimulation (DBS) for Parkinson's Disease (PD), Essential Tremor (ET), or dystonia.

What is the current status of trial NCT00998660?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2009-07. Estimated completion is 2013-07.

What interventions are being tested in trial NCT00998660?

The interventions under investigation include: Activa RC (DEVICE).

Who is sponsoring clinical trial NCT00998660?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00998660's enrollment target sits among peer trials

100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00998660, the US trial registry maintained by the National Library of Medicine. NCT00998660 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.